Dhanushki Wickramarachchi

Dhanushki Wickramarachchi

Auto-generated profile, based on publicly available information

Dhanushki Wickramarachchi

Nutritional Biochemistry Program, National Institute of Fundamental Studies

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Natural Product Research
Verified
Journal Article
Closed access
Pathumi Madhushika AriyarathnaPathumi Madhushika Ariyarathna
Pathumi Madhushika Ariyarathna
DWDhanushki Wickramarachchi
Dhanushki Wickramarachchi
RVRizliya Visvanathan
Rizliya Visvanathan
MQMallique Qader
Mallique Qader
ADAfka Deen
Afka Deen
RLRuvini Liyanage
Ruvini Liyanage
This study assessed the in vitro anti-diabetic potential and bioactive constituents of ten Sri Lankan medicinal herbs. Initial screening of aqueous extracts for starch-digesting enzyme inhibition prioritised three plants with notable activity (p ≤ 0.05), for further assessment using methanolic extracts: Phyllanthus emblica (PE), Cassia auriculata (CA), and Hemidesmus indicus (HI). The selected plants were tested for starch-digesting enzyme inhibition, cytotoxicity, and bioactive metabolite identification, with PE subjected to GC-MS and LC-HRMS analyses. All three extracts contained alkaloids, flavonoids, tannins, and terpenoids, except saponins and steroids in PE. GC-MS analysis of PE annotated ten compounds, eight with anti-diabetic properties, while LC-HRMS annotated thirty metabolites, including fourteen anti-diabetic compounds. Cell viability assessments confirmed the non-toxic nature of PE, CA, and HI. The significant enzyme inhibition and non-toxic nature of PE highlight its potential to treat type 2 diabetes. Further in vivo and clinical studies are essential to determining effective dosage and toxicity levels.